Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients

Conclusion: Peptide receptor radionuclide therapy in sarcoidosis is feasible and might be a new valuable tool in patients with otherwise treatment-refractory disease. Given the long experience with and good tolerability of PRRT, further evaluation of this new treatment option for otherwise treatment-refractory sarcoidosis in larger patient cohorts is warranted.

Source: Theranostics - June 20, 2018 Category: Molecular Biology Authors: Constantin Lapa, Malte Kircher, Heribert H ä nscheid, Andreas Schirbel, G ö tz Ulrich Grigoleit, Erdwine Klinker, Markus B ö ck, Samuel Samnick, Theo Pelzer, Andreas K Buck Tags: Research Paper Source Type: research